-
A Precision Medicine Blitz in China
Jan 6, 2016, 09:38 AM by Michael CroftNature News | A new push by the Chinese government for research in genomic health is expected to dwarf the U.S. Precision Medicine Initiative in both scale and funding, although China's shortage of physicians and drug development capacity may make it hard to capitalize on new discoveries.Full story -
Editas Medicine Files for CRISPR Technology's First IPO
Jan 5, 2016, 12:15 PM by Michael CroftBio-IT World | Still facing a looming patent dispute over its most basic intellectual property, Editas Medicine registered with the SEC for an initial public offering this week, making it the first therapeutics company based on CRISPR-Cas9 gene editing to go public.Full story -
Who Can Host Biology's Big Data?
Jan 4, 2016, 11:41 AM by Michael CroftForbes | The National Institutes of Health expects to shortly phase out its funding for the maintenance of databases like Online Mendelian Inheritance in Man, leaving the future of these invaluable resources for the life sciences uncertain.Full story -
December News and Product Briefs
Dec 30, 2015, 08:05 AM by Michael CroftBio-IT World | The latest products and announcements from around the industry, including the tranSMART Foundation absorbing the OpenBEL project, and an expanded organs-on-chips program at Merck.Full story -
Social Problems due to Drug Abuse Driving Substance Abuse Treatment Market
Dec 30, 2015, 03:16 AM by Michael CroftALBANY, NY, UNITED STATES - Dec 30, 2015 - Substance abuse refers to the use of psychoactive substances, which include alcohol and illicit drugs, to the extent that it is harmful or hazardousFull story -
Silicon Valley's Dubious Biotech Investments
Dec 29, 2015, 13:14 PM by Michael CroftThe Verge | Verge Editors Elizabeth Lopatto and Ben Popper discuss high-tech investors' vulnerability to shaky claims in the life sciences.Full story -
The Fuzzy Definition of 'GMO'
Dec 28, 2015, 11:15 AM by Michael CroftGrist | The tangled history of agricultural technology, and nature's dazzling array of genetic interventions, make it intractably hard to come up with a crisp, consistent meaning for "genetically modified organism."Full story -
Wellcome Trust Introduces Mykrobe Predictor for Genetic Analysis of Antibiotic Resistance
Dec 23, 2015, 14:30 PM by Michael CroftBio-IT World | A large team of researchers led by Zamin Iqbal of the Wellcome Trust Centre for Human Genetics has published a new software tool that rapidly identifies antibiotic-resistant bacteria using DNA data, beginning with studies of Staphylococcus aureus and Mycobacterium tuberculosis.Full story -
Foundation Medicine, UnitedHealthcare Sign Lung Cancer Profiling Agreement
Dec 22, 2015, 17:00 PM by Michael CroftBio-IT World News Brief | Foundation Medicine has signed an agreement with UnitedHealthcare to offer FoundationOne, a comprehensive genomic profiling assay for solid tumors, to patients with metastatic stage IV non-small cell lung cancer (NSCLC).Full story -
Triumph of the Public Cloud
Dec 22, 2015, 15:44 PM by Michael CroftWired | A decade after the launch of Amazon Web Services, there has been a seismic shift in attitudes toward the transfer of computing to cloud services.Full story -
OrbiMed Launches New VC Fund with $950m
Dec 21, 2015, 16:00 PM by Michael CroftFull storyBio-IT World News Brief | OrbiMed, a leading investment firm focused on the healthcare sector, today announced the closing of its next venture capital fund, OrbiMed Private Investments VI, LP, with $950 million in limited partner commitments.
-
New Persephone Technology to Be Demonstrated at Genome Conference
Dec 21, 2015, 12:42 PM by Michael CroftTHOUSAND OAKS, CA - Dec 21, 2015 - Ceres, Inc. (NASDAQ: CERE), an agricultural biotechnology company, today announced that its genomics team will demonstrate new features of its Persephone software technology at the upcoming International Plant and Animal Genome Conference in San Diego, CalifFull story -
U.S. Department of Energy Awards $13.5M to Enhance Sorghum for Biofuel
Dec 21, 2015, 10:40 AM by Michael CroftST. LOUIS, MO, UNITED STATES - Dec 21, 2015 - The Donald Danforth Plant Science Center announced that it will be part of a major collaborative research project to improve sorghum's productivity under resource-limited conditionsFull story -
GENEWIZ Acquires the Genomic Services Business of Beckman Coulter
Dec 21, 2015, 10:05 AM by Michael CroftSOUTH PLAINFIELD, NJ, UNITED STATES - Dec 21, 2015 - Leading global genomics service provider, GENEWIZ, has signed a definitive agreement to acquire the genomic services business of Beckman Coulter, which delivers expert genomics sequencing solutions to healthcare businesses, as well as academic and government institutions worldwide (GS)Full story -
Bayer, CRISPR Therapeutics Form $335M+ Gene Editing Venture
Dec 21, 2015, 09:14 AM by Michael CroftXconomy | Bayer and CRISPR Therapeutics have signed a pact that could be worth more than $335 million to develop CRISPR-based drugs for a variety of diseases starting with blindness, blood disorders, and congenital heart disease.Full story -
The Personal Genome Project, Ten Years Later
Dec 18, 2015, 13:01 PM by Michael CroftTechonomy | A decade ago, the Personal Genome Project became the first massive study of people sharing their full genome information. Many thought it unlikely to succeed.Full story -
Juniper warns about spy code in firewalls
Dec 18, 2015, 09:33 AM by Michael CroftComputerworld | Juniper, a major manufacturer of networking equipment, said on Thursday it found spying code planted in certain models of its firewalls, an alarming discovery that echoes of state-sponsored tampering.Full story -
AMP, FDA Debate Regulation of Laboratory-Developed Tests
Dec 17, 2015, 13:15 PM by Michael CroftBio-IT World | The Association of Molecular Pathology (AMP) accused the Food and Drug Administration of fabricating some of the examples included in a recent FDA report outlining the public health evidence for FDA oversight of laboratory-developed tests.Full story -
Congress Gives Big Funding Increase to NIH
Dec 16, 2015, 15:40 PM by Michael CroftSTAT | The spending bill for the federal government, still pending passage, ends more than 12 years of stagnant budgets for NIH with a $2 billion raise.Full story -
Long-Read Sequencing in the Age of Genomic Medicine
Dec 16, 2015, 13:45 PM by Michael CroftDiagnostics World | Long-read sequencing today is mostly a curiosity of basic research, but Roche Diagnostics is now planning to commercialize it for clinical testing with a high-throughput instrument launch in 2016. Robert Sebra, Director of Technology Development at Mount Sinai, tells us where he sees the most promise in using long-read sequencing to diagnose and treat patients.Full story